Literature DB >> 1552310

Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study.

K Lauer1, W Firnhaber.   

Abstract

Demographic and clinical features and data on medical history and prior environmental exposure collected during an epidemiological long-term study of multiple sclerosis (MS) were tested for their possible prognostic value. Fifty-two benign MS patients were compared with 29 patients having a malignant course. A primary or secondary progressive course and cerebellar/lower brain-stem symptoms at onset indicated an unfavourable course, whereas no predictive value of sex or of any other type of onset symptomatology was found. Age at onset per se had no influence on prognosis but was associated with more rapid progression only by its relationship with a chronic progressive type of course. Prior illness, surgery, trauma and childhood exposure to defined environmental factors could not be identified as relevant for prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1552310     DOI: 10.1007/bf00862981

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  [IS THERE A BENIGN COURSE OF MULTIPLE SCLEROSIS?].

Authors:  K POECK; P MARKUS
Journal:  Munch Med Wochenschr       Date:  1964-11-27

2.  Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis.

Authors:  W W Beatty; D E Goodkin; N Monson; P A Beatty; D Hertsgaard
Journal:  Arch Neurol       Date:  1988-06

3.  A clinical and laboratory study of benign multiple sclerosis.

Authors:  A J Thompson; M Hutchinson; J Brazil; C Feighery; E A Martin
Journal:  Q J Med       Date:  1986-01

4.  Cognitive impairment in patients with multiple sclerosis and mild physical disability.

Authors:  W van den Burg; A H van Zomeren; J M Minderhoud; A J Prange; N S Meijer
Journal:  Arch Neurol       Date:  1987-05

5.  Prognostic relevance of initial clinical and paraclinical parameters for the course of multiple sclerosis.

Authors:  C Hartard; K Spitzer; K Kunze; A Brinkhus; R Laubach
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

6.  A comparison of sporadic and familial multiple sclerosis.

Authors:  B G Weinshenker; D Bulman; W Carriere; J Baskerville; G C Ebers
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

7.  Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg.

Authors:  T Broman; O Andersen; L Bergmann
Journal:  Acta Neurol Scand       Date:  1981-01       Impact factor: 3.209

8.  [Factors affecting the disease course in multiple sclerosis].

Authors:  K Lakner
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1990-08

9.  Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients.

Authors:  A Citterio; G Azan; R Bergamaschi; A Erbetta; V Cosi
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

10.  Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis.

Authors:  E Schmutzhard; P Pohl; G Stanek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

View more
  1 in total

Review 1.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.